Andrew Wilks

Fundador en SYN thesis med chem Pty Ltd. .

Health Technology

Commercial Services

Perfil

Andrew Wilks is the founder of SYN thesis med chem Pty Ltd.
He is currently a Director at Medicines Development for Global Health Ltd and a Non-Executive Director at Chuangsheng Qiao Kang Pharmaceutical Co., Ltd.

Cargos activos de Andrew Wilks

Empresas	Cargo	Inicio
Medicines Development for Global Health Ltd Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia.	Director/Miembro de la Junta	-
SYN thesis med chem Pty Ltd. SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia.	Fundador	-
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer.	Director/Miembro de la Junta	-

Todos los cargos activos de Andrew Wilks

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Andrew Wilks.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas privadas	3
Medicines Development for Global Health Ltd Medicines Development for Global Health Ltd Pharmaceuticals: MajorHealth Technology Medicines Development Ltd. engages in the development of medicines and vaccines. Its development programs include Moxidectin Program, Global Health Programs, and Consulting ervices. The company was founded by Mark Sullivan in 2005 and is headquartered in Melbourne, Australia.	Health Technology
SYN thesis med chem Pty Ltd. SYN thesis med chem Pty Ltd. BiotechnologyHealth Technology SYN thesis med chem Pty Ltd. engages in the development and provision of molecule drug discovery services. It offers integrated drug discovery, medicinal and synthetic chemistry, single compound synthesis, and catalogue products. The company was founded by Andrew Wilks and Xian Bu and is headquartered in Parkville, Australia.	Health Technology
Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Chuangsheng Qiao Kang Pharmaceutical Co., Ltd. develops ocular therapeutics and treatments for rare diseases. The private company is based in Beijing, CN. and has subsidiaries in the United States. The CEO of the Chinese company is Darren Mercer.	Commercial Services

Ver las conexiones de la empresa